Source: J Drugs Dermatol. 2018;17(11):1169-1172.
Eliot F. Battle Jr. MD and Sally Battle CNMT
We are excited to highlight a November 2018 published in the Journal of Drugs in Dermatology by our very own co-founder, Eliot F. Battle, MD. The study was intended to evaluate the safety and efficacy of fractional RF technology for the treatment of patients with Fitzpatrick skin type VI. We recommend you read the abstract or login with your JDD subscription for the full manuscript here.